In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ardea Biosciences Inc.

Division of AstraZeneca PLC
www.ardeabio.com

Latest From Ardea Biosciences Inc.

Finance Watch: Relay Raises $400m – And It's Only The Third-Largest Biopharma VC Round Of 2018

The company isn't relaying any details about its drug targets, but will use the mega-round to take its first candidates into the clinic. Also, RiverVest raises a $184.4m VC fund, Annexon closes a $75m Series C, Takeda lists its stock in the US, and Aptorum goes public.

Financing Business Strategies

Brii Builds China Ops With Hep B Assets, New Partnerships

China-focused Brii Biosciences, formed earlier this year, unveils plans to take its first projects into the clinic by way of deals with VBI and Vir for hepatitis B, and builds other alliances and operations in the country.

China Commercial

Brii Bio: Partnering To Bring Innovation To China

Emerging Company Profile: Brii Bio has been set up in Shanghai with robust initial funding and a handful of founding partnerships to help in its goal of accelerating innovation and optimizing access to the latest medicines for Chinese patients, with a focus on treatments for chronic illnesses with significant burdens, including infectious diseases, liver and lung disorders.

China Commercial

US Approvals Roundup: Cyltezo Biosimilar, Victoza CV Benefit, Gocovri In PD, Kedrab Rabies Biologic, Gout Combo Duzallo

FDA's clearances showcase the application of formulation technology to reduce problem side effects and improve convenience of available drugs.

Approvals Biosimilars
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • IntraBiotics Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • AstraZeneca PLC
  • Senior Management
  • James Mackay, PhD, Pres. & COO
    John P Montana, VP, Project Management & Fin.
  • Contact Info
  • Ardea Biosciences Inc.
    Phone: (858) 652-6500
    9390 Towne Centre Dr.
    San Diego, CA 92121
    USA
UsernamePublicRestriction

Register